Effect of Preoperative Silodosin on Feasibility of Ureteral Access Sheath Insertion

Launched by AL-AZHAR UNIVERSITY · Apr 16, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called silodosin on a procedure used to treat kidney stones. When doctors perform a flexible ureteroscopy, they sometimes use a device called a ureteral access sheath (UAS) to help them reach and remove stones from the urinary tract more easily. However, inserting this device can be challenging if the ureter (the tube connecting the kidney to the bladder) is tight. Silodosin may help relax the ureter, making it easier and safer to insert the UAS, which can reduce pain and the risk of injury during the procedure.

To be eligible for the trial, participants should be adults aged 18 and older who have kidney stones and are scheduled to have flexible ureteroscopy with the use of a UAS. The trial is currently recruiting participants, and those who join can expect to receive silodosin before their procedure, with the goal of making the insertion of the UAS smoother and less painful. It's important to note that this trial does not include children. Overall, the study aims to find a better way to prepare for kidney stone surgery that could improve patient comfort and outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients with renal stones who will undergo flexible ureteroscopy and planned for using ureteral access sheath
• Exclusion Criteria:
• • Paediatric age group (less than 18 year)